Background: Malaria remains one of the major causes of childhood mortality in many parts of the world, especially in the sub-Saharan Africa, including Nigeria. Increasing chemotherapeutic failure and side effects of available antimalarial drugs have promoted the use of natural herbs for the treatment of malaria in Nigerian communities.

Objective: To study the phytosuppression of P berghei by Nauclea latifolia and its effects on the indices of anaemia and pancreatic beta cell function in experimental mice.

Methods: Fifty mice were divided into 10 groups (n=5) and used for the study. Group 1 (control) were uninfected but given placebo. Group 2 were infected with P berghei and treated with placebo. Groups 3, 4, 5, 8, 9 and 10 received N. latifolia treatment, while Groups 6 and 7 received standard chloroquine treatment. Groups 3, 4, 5 and 6 were however infected with the malarial parasite. Blood samples were collected by heart puncture and prepared for the estimation of haemoglobin, insulin and glucose. The pancreatic beta cell function (HOMA-beta) was determined using the fasting serum insulin and glucose levels as documented.

Results: P. berghei malaria infection caused a significant reduction in haemoglobin that led to anaemia in the mice, There were elevated HOMA-beta) in the parasitized and chloroquine treated groups, suggesting possible pancreatic beta cell dysfunction. Treatment with N. latifolia showed parasitaemia suppression and' improved pancreatic beta cell function and haemoglobin concentrations.

Conclusion: N. latifolia contains bioactive phytochemicals that suppresses malaria parasite multiplication and improves pancreatic beta cell function.

Download full-text PDF

Source

Publication Analysis

Top Keywords

pancreatic beta
24
beta cell
24
cell function
20
nauclea latifolia
8
groups received
8
treatment groups
8
insulin glucose
8
pancreatic
6
beta
6
cell
6

Similar Publications

Protective effect of CK2 against endoplasmic reticulum stress in pancreatic β cells.

Diabetol Int

January 2025

Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.

Unlabelled: Endoplasmic reticulum (ER) stress due to obesity or systemic insulin resistance is an important pathogenic factor that could lead to pancreatic β-cell failure. We have previously reported that CCAAT/enhancer-binding protein β (C/EBPβ) is highly induced by ER stress in pancreatic β cells. Moreover, its accumulation hampers the response of these cells to ER stress by inhibiting the induction of the molecular chaperone 78 kDa glucose-regulated protein (GRP78).

View Article and Find Full Text PDF

Unraveling the pathophysiology of type 2 diabetes with a new selectively bred animal model, the Oikawa-Nagao mouse.

Diabetol Int

January 2025

Department of Endocrinology, Metabolism and Nephrology, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo, 113-8603 Japan.

Type 2 diabetes (T2D) is a polygenic disease, and the development of animal models by selective breeding is crucial for understanding its etiology, pathophysiology, complications, and treatments. We recently developed a new T2D model, the Oikawa-Nagao (ON) mouse, by selectively breeding mice with inferior glucose tolerance [diabetes-prone (ON mouse DP®; ON-DP) strain] and superior glucose tolerance [diabetes-resistant (ON mouse DR®; ON-DR) strain] on a high-fat diet. ON-DP mice are predisposed to develop diabetes and obesity after being fed a high-fat diet, compared to ON-DR mice.

View Article and Find Full Text PDF

Differentiation, reduction, and proliferation of pancreatic β-cells and their regulatory factors.

Diabetol Int

January 2025

Clinical Research Department, Institute of Biomedical Research and Innovation (IBRI), Foundation for Biomedical Research and Innovation at Kobe (FBRI), 6-3-7 Minatojima Minami-machi, Chuo-ku, Kobe, Hyogo 650-0047 Japan.

The prevalence of diabetes has increased rapidly in recent years, and many types of therapeutic agents have been developed. However, the main purpose of these drugs is to lower blood glucose levels, and they are not fundamental solutions. In contrast, our research has been aimed at stimulating and inducing β-cell proliferation in vivo and replenishing β-cells.

View Article and Find Full Text PDF

Pancreatic β cell-secreted factor FGF23 attenuates Alzheimer's disease-related amyloid β-induced neuronal death.

PNAS Nexus

January 2025

Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, 1-1-1 Daigaku-dori, Sanyo Onoda City, Yamaguchi 756-0884, Japan.

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by cognitive decline and memory impairment. The pathophysiology of AD may involve aggregated amyloid β (Aβ) accumulation, which may underlie the disease mechanism. Patients with diabetes exhibit an elevated risk of developing AD, indicating potential therapeutic implications upon elucidating the underlying mechanisms.

View Article and Find Full Text PDF

Pancreatic β-cell damage is a critical pathological mechanism in the progression of obese type 2 diabetes mellitus (T2DM). However, the exact underlying mechanism remains unclear. We established an obese T2DM mouse model via high-fat diet feeding.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!